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We present a 63-year-old man treated with alemtuzumab for chronic lymphocytic leukemia who developed multiple angiomatous
papules and fever. Real-time polymerase chain reaction (RT-PCR) from a skin lesion and blood sample revealedBartonella quintana
as causative agent confirming the diagnosis of bacillary angiomatosis with bacteremia. Treatment with doxycycline, initially in
combination with gentamicin, led to complete resolution of the lesions. This case shows the importance of considering bacillary
angiomatosis as a rare differential diagnosis of angiomatous lesions in the immunocompromised patient, particularly in chronic
lymphocytic leukemia and following lymphocyte depleting treatments as alemtuzumab.
1. Introduction
Bacillary angiomatosis is a rare vasculoproliferative disorder
due to Bartonella henselae orBartonella quintana.The disease
usually manifests as cutaneous angioma-like tumour. Lesions
may be solitary or multiple and dissemination to visceral
organs can occur. Bone lesions and subcutaneous masses
are associated with B. quintana, whereas peliosis hepatis
and lymph node lesions are associated with B. henselae
[1]. Cases were usually described in HIV infected individ-
uals. Although less common, the infection was reported
in immunocompetent patients and in otherwise immuno-
compromised conditions such as solid organ transplantation
and oncology patients, particularly in chronic lymphocytic
leukemia [2, 3]. Because of its potentially life-threatening
course, early diagnosis and adequate treatment are crucial.
To our knowledge, we describe the first case of bacillary
angiomatosis and bacteremia due to B. quintana in a patient
with chronic lymphocytic leukemia.
2. Case Presentation
A 63-year-old man was admitted for evaluation of multiple
nonpruritic skin lesions that had been present for 1 month
on his arms, legs, trunk, and face. His medical history was
significant for chronic lymphocytic leukemia with longstand-
ing profound neutropenia, anemia, and thrombocytopenia.
He had previously been treated with chlorambucil and pred-
nisone, aswell as cladribine, rituximab, and bendamustine. At
the time of presentation, he had been receiving alemtuzumab
for 4 months. Current medication included prophylaxis with
trimethoprim sulfamethoxazole as well as valacyclovir, and
treatmentwith voriconazole for probable invasive pulmonary
aspergillosis diagnosed during a previous febrile neutropenic
episode. There had been several other episodes of neu-
tropenic fever without specific infectious focus.
Physical examination showed multiple nontender cuta-
neous papules and nodules, resembling angiomatous lesions
up to 10mm in diameter (Figure 1). Some were crusted, and
some surrounded by an erythematous halo (Figure 2). On the
right forearm, there were signs of superinfection. Fever up to
39∘C was noted.
The white blood count was 2600/𝜇L (absolute neu-
trophil count 2500/𝜇L, lymphocytes 70/𝜇L, CD4 cells
10/𝜇L, 12%, eosinophils 0/𝜇L, monocytes 100/𝜇L), CRP was
117mg/L, and chemistry panel and urine analysis were oth-
erwise unremarkable. Computertomography revealed known
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Figure 1: Multiple vascular nodules and papules.
Figure 2: Angioma-like lesions with surrounding erythematous
halo.
hilomediastinal and axillary lymphadenopathy, unchanged
splenomegaly without focal lesions, and minimal residual
pulmonary infiltrates and cavernation from the formerly
diagnosed aspergillosis.
Biopsy of the skin revealed features of pyogenic
granuloma with lobular proliferation of small vessels and
mixed cell, predominantly neutrophilic inflammation
(Figures 3 and 4). No microorganisms were detected on
special stains as Warthin-Starry, Giemsa, Gram, or Grocott.
There were no morphological signs of Kaposi sarcoma or of
a vascular tumor such as hemangioendothelioma.
Routine culture of skin and blood specimens showed
no bacterial growth. However, RT-PCR for B. quintana [4,
5] was positive in a skin biopsy as well as from a blood
specimen (Figure 5), confirming bacillary angiomatosis with
bacteremia. To rule out endocarditis, echocardiography was
performed, which showed no relevant valvulopathies or
vegetations.
We started antibiotic treatment with doxycycline and
gentamicin. In addition, amoxicillin/clavulanate for super-
infection of the right forearm was administered for 10
days. Gentamicin was stopped after two weeks, followed by
doxycycline of 6 months duration. The patient defervesced
promptly and all the lesions resolved within few weeks.
Figure 3: Polypoid granuloma pyogenicum-like lesion with ectatic,
lobular vascular proliferation (hematoxylin-eosinstaining, 10×).
Figure 4: Mixed-cell infiltrates, predominantly granulocytes
(hematoxylin-eosinstaining, 40×).
3. Discussion
The causative organism of bacillary angiomatosis in different
case series was found to be B. henselae in 28% and 53%,
respectively, and B. quintana in 64% and 47%, respectively
[6, 7]. B. quintana infection in bacillary angiomatosis is
associated with homelessness, low socioeconomic status and
exposure to lice [7]. B. quintana was first recognized as an
etiological agent of trench fever, a recurrent fever transmitted
by body lice occurring in troops during World War I,
whereas cat scratch disease ismainly attributed toB. henselae.
B. quintana and B. henselae have worldwide distribution.
Other clinical features of B. quintana are chronic bacteremia,
endocarditis, and lymphadenopathy. Relapses of trench fever
can occur many years after the initial illness or the patients
may be bacteremic but have no clinical signs, as was noted in
outbreaks of urban trench fever among homeless people [8].
Prolonged bacteremias in patients withB. quintana infections
possibly contribute to the development of endocarditis and
bacillary angiomatosis [9]. In contrast to B. henselae, B.
quintana can cause endocarditis in previously intact heart
valves. Our patient was a retiree originating fromMazedonia
who had lived in Switzerland for 33 years working as a brick-
layer. There was no history of cat exposure, homelessness,
pediculosis, or alcoholism in our patient. Unfortunately we
could not establish if it was a relapse of a previous disease
or if the relapsing neutropenic fever episodes were also due
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Figure 5: Bartonella quintana specific RT-PCR analysis of DNA
extracts of skin biopsy (a) and blood (b).
to Bartonella. Because of prolonged bacteremia echocardio-
graphic imaging was performed revealing no valvulopathies
or signs of endocarditis.
Chronic lymphocytic leukemia appears to be a particular
risk for acquiring bacillary angiomatosis due to a T-cell
dysfunction similar to that of HIV patients. The depletion
of CD4 cells in our patient was similar to that observed
in AIDS patients, in which bacillary angiomatosis was first
described in the 80s of the past century. We found five
case reports of bacillary angiomatosis occurring in chronic
lymphocytic leukemia patients [3, 10–13]. Most cases were
diagnosed by histology, and only in one case B. henselae
was identified as causative agent by PCR in a cutaneous
specimen [12]. To our knowledge this is the first description
of bacillary angiomatosis due to B. quintana in a patient with
chronic lymphocytic leukemia. Furthermore, administration
of alemtuzumab, a monoclonal anti CD52 antibody causing
lymphocyte depletion, might have contributed to the partic-
ular susceptibility.
As in our case, the diagnosis of bacillary angiomatosis
can be confirmed by detection of Bartonella species DNA
in biopsy extracts by PCR. Identification of Bartonella by
culturing is fastidious and not sensitive. Although detection
of the organism in conventional cultures as performed in our
patient is possible, the sensitivity could have been improved
by subculture, special media, and prolonged incubation [6].
Serologymay be unreliable in immunocompromised patients
due to lack of antibody response [14]. Histopathology can
help establishing diagnosis of cutaneous bacillary angiomato-
sis.
In vitro and in vivo activities of antibiotics against Bar-
tonella species often differ. In epidemiological investigation
trimethoprim sulfamethoxazole, ciprofloxacin, penicillins,
and cephalosporins were not protective against Bartonella
infections whereas doxycycline, tetracycline, rifampin or a
macrolide were [7]. Gentamicin and rifampin were the only
agents found to be bactericidal against B. quintana [15].
Erythromycin or doxycycline for the duration of 3months are
the drugs of choice for the treatment of bacillary angiomato-
sis. We preferred an initial combination of doxycycline and
gentamicin because of bacteremia, as outlined in treatment
recommendations for trench fever, chronic bacteremia, or
endocarditis [16]. Based on the increased risk of relapse by
ongoing immunosuppression in our patient, the following
treatment periodwith doxycyclinewas extended to 6months.
In conclusion, bacillary angiomatosis should be consid-
ered a differential diagnosis in immunosuppressed patients
presenting with cutaneous angioma-like lesions. Particular
attention should be addressed to conditions such as chronic
lymphocytic leukemia and T-cell depleting therapies.
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